Background: Atrophic rhinitis (AR) is a chronic progressive condition characterized by formation of thick dry crusts in a roomy nasal cavity, which has resulted from progressive atrophy of the nasal mucosa and absorption of underlying bone. The various symptoms which result from the primary nasal pathology and its sequelae may comprise foul smelling thick black or greenish crust, nasal obstruction, epistaxis, and anosmia. Atrophic rhinitis can be classed as primary or, where it is a consequence of another condition, secondary. The use of synthetic implants has been studied in ENS reconstructive surgery. These implant types include silicone perforated sheeting or porous polyethylene (MedPor, Stryker Corporation, Kalamazoo, MI, USA). These materials do not react and are designed to allow tissue growth to penetrate the material and improve long-term integration. Synthetic implants are generally inexpensive and easy to obtain in most practices. Since synthetic implants are foreign bodies by nature, infection, and extrusion are possible complications. After tissue ingrowth, implant removal due to scarring is challenging if such extraction is warranted.